ReviewFrontiers in immunology2025
Small molecules as ligands in the tuning of immune regulatory receptors.
Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gut microbiota-immune crosstalk in osteoarthritis: pathogenic mechanisms and emerging therapeutic opportunities.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Professional antigen-presenting cells (APCs) represent a crucial link between the innate and the adaptive immune response. APCs express specific surface receptors which are primarily involved in "non-self" and/or "self" ligand recognition. Upon ligand binding, these receptors can trigger cell signalling leading to the production of pro-inflammatory cytokines, chemokines and Type 1 interferons, supporting antimicrobial and inflammatory responses. Recently, two major families of receptors, C-type lectin receptors and immunoglobulin receptors, are emerging as potential therapeutic targets to activate and modulate immune system through different intracellular signalling motifs upon binding with endogenous and exogenous ligands. The chemical characterization of the molecular determinants necessary for the receptors/ligands binding promotes the design and optimization of small molecules crucial for the comprehension of biological functions and for the therapeutic treatment of specific receptor-associated disorders. This review focuses on the description of these ligands together with their biological evaluation and their impact on the modulation of the immune response.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.